Lymphocyte-to-C-Reactive Protein Ratio: A Novel Predictor of Adverse Outcomes in COVID-19

BACKGROUND: Systemic inflammation elicited by a cytokine storm is considered a hallmark of coronavirus disease 2019 (COVID-19). This study aims to assess the validity and clinical utility of the lymphocyte-to-C-reactive protein (CRP) ratio (LCR), typically used for gastric carcinoma prognostication,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Waqas, Basyal, Bikash, Tariq, Shafaq, Almas, Talal, Saeed, Rehan, Roomi, Sohaib, Haq, Shujaul, Madara, John, Boigon, Margot, Haas, Donald C., Fischman, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331862/
https://www.ncbi.nlm.nih.gov/pubmed/32655735
http://dx.doi.org/10.14740/jocmr4227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331862/
https://www.ncbi.nlm.nih.gov/pubmed/32655735
http://dx.doi.org/10.14740/jocmr4227

Ejemplares similares